Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Atrial Fibrillation
NCT05928728Phase 3Recruiting
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Jul 2023
- Primary completion
- Jun 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Atrial fibrillation (AFib), sponsored by Herlev & Gentofte Hospital. Started Jul 2023; status: recruiting.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05928728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05928728.